Altay MF, Liu AKL, Holton JL, Parkkinen L, Lashuel HA (2022) Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta Neuropathol Commun 10:1–18. https://doi.org/10.1186/s40478-022-01468-8

Article  CAS  Google Scholar 

Amunts K, Kedo O, Kindler M, Pieperhoff P, Mohlberg H, Shah NJ et al (2005) Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: Intersubject variability and probability maps. Anat Embryol (Berl) 210:343–352. https://doi.org/10.1007/S00429-005-0025-5

Article  CAS  PubMed  Google Scholar 

Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Rep 7:1–7. https://doi.org/10.1038/s41598-017-17204-5

Article  CAS  Google Scholar 

Beach TG, Adler CH, Lue LF, Sue LI, Bachalakuri J, Henry-Watson J et al (2009) Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613–634. https://doi.org/10.1007/s00401-009-0538-8

Article  PubMed  PubMed Central  Google Scholar 

Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2017) Alpha-synuclein oligomers: a new hope. Acta Neuropathol 134:819–838. https://doi.org/10.1007/s00401-017-1755-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F et al (2024) Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathol 147:1–13. https://doi.org/10.1007/S00401-023-02663-0

Article  Google Scholar 

Berkhoudt Lassen L, Gregersen E, Kathrine Isager A, Betzer C, Hahn Kofoed R, Henning Jensen P (2018) ELISA method to detect α-synuclein oligomers in cell and animal models. PLoS One 13:e0196056. https://doi.org/10.1371/JOURNAL.PONE.0196056

Article  Google Scholar 

Berwick DC, Heaton GR, Azeggagh S (2019) Harvey K (2019) LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same. Mol Neurodegener 14:1–22. https://doi.org/10.1186/S13024-019-0344-2

Article  Google Scholar 

Blauwendraat C, Pletnikova O, Geiger JT, Murphy NA, Abramzon Y, Rudow G et al (2019) Genetic analysis of neurodegenerative diseases in a pathology cohort. Neurobiol Aging 76:214.e1-214.e9. https://doi.org/10.1016/J.NEUROBIOLAGING.2018.11.007

Article  PubMed  Google Scholar 

Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, Parkkinen L, Myllykangas L (2021) Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol Dis 161:105557. https://doi.org/10.1016/j.nbd.2021.105557

Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134

Article  PubMed  Google Scholar 

Braak H, Del Tredici K, Rüb U, De Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211. https://doi.org/10.1016/S0197-4580(02)00065-9

Article  PubMed  Google Scholar 

Cabezudo D, Tsafaras G, Van Acker E, Van den Haute C, Baekelandt V (2023) Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis. Acta Neuropathol 146:245–261. https://doi.org/10.1007/S00401-023-02595-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cherian A, Divya KP (2020) Genetics of Parkinson’s disease. Acta Neurol Belg 120:1297–1305. https://doi.org/10.1007/S13760-020-01473-5

Article  PubMed  Google Scholar 

Covy JP, Yuan W, Waxman EA, Hurtig HI, Van Deerlin VM, Giasson BI (2009) Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations. Mov Disord 24:32–39. https://doi.org/10.1002/MDS.22096

Article  PubMed  PubMed Central  Google Scholar 

Dächsel JC, Ross OA, Mata IF, Kachergus J, Toft M, Cannon A et al (2007) Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathol 113:601–606. https://doi.org/10.1007/S00401-006-0178-1

Article  PubMed  Google Scholar 

Day JO, Mullin S (2021) The genetics of Parkinson’s disease and implications for clinical practice. Genes 12:1006. https://doi.org/10.3390/GENES12071006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM et al (2009) Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol 8:1150–1157

Article  CAS  PubMed  Google Scholar 

Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE et al (2013) Parkin disease: a clinicopathologic entity? JAMA Neurol 70:571–579. https://doi.org/10.1001/JAMANEUROL.2013.172

Article  PubMed  PubMed Central  Google Scholar 

Duffy PE, Tennyson VM (1965) Phase and electron microscopic observations of lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson’s disease. J Neuropathol Exp Neurol 24:398–414. https://doi.org/10.1097/00005072-196507000-00003

Article  Google Scholar 

Gai WP, Blumbergs PC, Geffen LB, Blessing WW (1992) Age-related loss of dorsal vagal neurons in Parkinson’s disease. Neurology 42:2106–2111. https://doi.org/10.1212/WNL.42.11.2106

Article  CAS  PubMed  Google Scholar 

Gaig C, Martí MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E (2007) G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies. J Neurol Neurosurg Psychiatry 78:626–628. https://doi.org/10.1136/JNNP.2006.107904

Article  PubMed  PubMed Central  Google Scholar 

German DC, Manaye KF, White CL, Woodward DJ, McIntire DD, Smith WK et al (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676. https://doi.org/10.1002/ANA.410320510

Article  CAS  PubMed  Google Scholar 

Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ et al (2006) Biochemical and pathological characterization of Lrrk2. Ann Neurol 59:315–322. https://doi.org/10.1002/ANA.20791

Article  CAS  PubMed  Google Scholar 

Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ et al (2005) A common LRRK2 mutation in idiopathic Parkinson’s disease. The Lancet 365:415–416. https://doi.org/10.1016/S0140-6736(05)17830-1

Article  CAS  Google Scholar 

Giordana MT, D’Agostino C, Albani G, Mauro A, Di Fonzo A, Antonini A et al (2007) Neuropathology of Parkinson’s disease associated with the LRRK2 Ile1371Val mutation. Mov Disord 22:275–278. https://doi.org/10.1002/MDS.21281

Article  PubMed  Google Scholar 

Gomez A, Ferrer I (2010) Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. Acta Neuropathol 120:155–167. https://doi.org/10.1007/S00401-010-0669-Y

Article  CAS  PubMed  Google Scholar 

Gómez-Suaga P, Luzón-Toro B, Churamani D, Zhang L, Bloor-Young D, Patel S et al (2012) Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP. Hum Mol Genet 21:511–525. https://doi.org/10.1093/HMG/DDR481

Article  PubMed  Google Scholar 

Halliday G, Reyes S, Double K (2012) Substantia Nigra, Ventral Tegmental Area, and Retrorubral Fields. Hum Nervous Syst. https://doi.org/10.1016/B978-0-12-374236-0.10013-6

Article  Google Scholar 

Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355–363. https://doi.org/10.1007/S004010100390

Article  CAS  PubMed